AMBUJACEM

Consolidating Near Support, Direction Awaited

s currently trading near an important support zone around the 510–520 levels after witnessing a gradual decline from higher levels. The price action shows consolidation rather than a strong reversal, while RSI remains near the mid-40s, indicating neutral momentum. ADX suggests moderate trend strength but not a decisive directional move. With the stock hovering close to key support and no strong breakout or breakdown yet, the risk-reward appears balanced. A clear move above resistance or a sustained break below support will likely decide the next trend, making a neutral stance appropriate for now.